Brain cancer drug trial halted early – no results yet
NCT ID NCT01068782
First seen Mar 12, 2026 · Last updated May 14, 2026 · Updated 9 times
Summary
This study tested the drug XL184 in 19 people whose grade IV brain tumors (a serious type of cancer) had come back after initial treatment. The goal was to see if the drug could shrink tumors or slow their growth. However, the company stopped the study early for business reasons, so we don't know if XL184 worked. The main information collected was about side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTROCYTIC TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Birmingham, Alabama, 35294, United States
-
Study site
Encinitas, California, 92024, United States
-
Study site
Pleasant Hill, California, 94523, United States
-
Study site
Chicago, Illinois, 60611, United States
-
Study site
Chicago, Illinois, 60637, United States
-
Study site
Boston, Massachusetts, 02115, United States
-
Study site
Detroit, Michigan, 48202, United States
-
Study site
Minneapolis, Minnesota, 55407, United States
-
Study site
Amherst, New York, 14226, United States
-
Study site
Rochester, New York, 14642, United States
-
Study site
Cleveland, Ohio, 44195, United States
-
Study site
Hershey, Pennsylvania, 17033, United States
-
Study site
Dallas, Texas, 75246, United States
-
Study site
Dallas, Texas, 75426, United States
-
Study site
San Antonio, Texas, 78229, United States
-
Study site
Charlottesville, Virginia, 22908, United States
-
Study site
Seattle, Washington, 98122, United States
-
Study site
Calgary, Alberta, Canada
-
Study site
Montreal, Quebec, Canada
Conditions
Explore the condition pages connected to this study.